Related Experiment Video
Updated: Jun 1, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Arterial stiffness and carotid intima-media thickness in HIV infected patients
Anamaria Papita1, Adriana Albu, Daniela Fodor
1Infectious Diseases Hospital, Cluj-Napoca, Romania. ancapapita@gmail.com
Insights
HIV infection and antiretroviral therapy (ART) increase carotid artery intima-media thickness and arterial stiffness, contributing to higher cardiovascular risk in patients. This study highlights vascular changes associated with HIV and its treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is a significant concern in HIV-infected individuals.
- Both HIV infection and antiretroviral therapy (ART) contribute to increased CVD risk.
- HIV can directly damage arterial walls, while ART may cause metabolic disturbances.
Purpose of the Study:
- To investigate the impact of HIV and ART on carotid artery intima-media thickness (C-IMT).
- To assess the effects of HIV and ART on arterial stiffness parameters.
- To evaluate the relationship between these vascular changes and cardiovascular risk in HIV patients.
Main Methods:
- A cross-sectional case-control study involving 63 HIV-infected patients (56 on ART, 7 ART-naive) and 36 controls.
- Carotid artery intima-media thickness (C-IMT) and arterial stiffness were measured using ultrasonography.
- Arterial stiffness parameters were assessed in the common carotid and brachial arteries.
Main Results:
- HIV-infected patients exhibited significantly greater C-IMT compared to controls (p<0.01).
- HIV patients showed altered arterial stiffness, including reduced carotid compliance (p<0.01).
- Patients on reverse transcriptase inhibitors (RTI) had increased stiffness index and carotid PWV, and reduced compliance compared to controls.
Conclusions:
- HIV infection and ART are associated with increased C-IMT and arterial stiffness in large arteries.
- These vascular modifications are potential contributors to the elevated cardiovascular risk observed in HIV-infected patients.
- Further research is warranted to mitigate these treatment-related vascular complications.
Background:
Cardiovascular disease is an increasing cause of morbidity and mortality in HIV-infected patients. The increased cardiovascular risk is linked to traditional risk factors for atherosclerosis but also, to HIV infection itself which can damage the arterial wall and the antiretroviral therapy (ART) implicated in metabolic disturbances. The aim of our study was to identify the effects of HIV and ART on carotid artery intima-media thickness (C-IMT) and on arterial stiffness, parameters which are used for the evaluation of cardiovascular risk.
Patients And Methods:
A cross-sectional case-control study of 63 HIV-infected patients (56 exposed to ART, 7 ART naive) and 36 controls matched for age and sex was performed. C-IMT, and arterial stiffness were measured ultrasonographically using an ALOKA ProSound α 10 echo-device. Parameters of arterial stiffness were measured at the common carotid and brachial arteries.
Results:
HIV-infected patients had a greater C-IMT than controls (p<0.01). There were significant differences regarding arterial stiffness parameters in HIV infected patients compared to controls, and between the groups of patients with different types of ART, especially at the level of carotid artery. Patients with HIV infection had reduced carotid compliance compared to controls (p<0.01). Patients exposed to reverse transcriptase inhibitort (RTI), had increased β stiffness index (p=0.01) and carotid PWV (p=0.02) and reduced carotid compliance (p<0.01) compared to controls.
Conclusions:
HIV infection and ARV treatment is associated with increased C-IMT, and an increase in the arterial stiffness of the large arteries. These vascular modifications are possible causes of increased cardiovascular risk observed in HIV infected patients.
More Related Videos
05:51Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
Published on: May 3, 2018
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Sexually Transmitted Infections
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation